In addition, the frequent observations in severe COVID-19 of marked elevations of plasma von Willebrand Factor (vWF), P-selectin, D-dimers and other coagulation activating factors provide indirect evidence that endothelial damage and the development of vasculopathy as a pivotal determinant of clinical outcome in many patients. The gene discussed is VWF; the disease is COVID-19.